跳至主要内容
临床试验/NCT06099587
NCT06099587招募中不适用

MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease

Rennes University Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年7月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Diffusion-MRI based parameters estimates of medial temporal lobe gray matter microstructure

研究概览

简要总结

Patients with Mild Cognitive Impairment (MCI) or Subjective Cognitive Decline (SCD) may or may not develop Alzheimer's disease (AD) dementia. Yet identifying patients at risk is crucial: delaying the onset of the disease by 5 years could reduce prevalence by 50%. To achieve this, we need affordable biomarkers combined with clinically meaningful assessment tools. Current approaches (cognition, imaging or Tau and Amyloid peptide assays) lack precision or specificity (e.g., age-related memory deficits) and involve invasive and costly procedures, sometimes inaccessible in France (e.g., the "AT(N)" framework). Recently, quantitative diffusion MRI (dMRI) has identified in-vivo gray matter microstructural changes linked to hyperphosphorylated Tau protein, which are of great diagnostic value. Still, we ignore whether and how these changes are responsible for early memory impairment in AD. The MIMA-P project will combine multi-compartment models of the high-resolution diffusion signal with a cognitive assessment of memory based on recent models of medial temporal lobe function to assess the relevance of a new affordable, rapid and non-invasive early marker of the disease.

详细描述

The study will combine multi-compartment models (e.g. Archer et al., 2020; Parker et al., 2020) of high-resolution diffusion MRI within medial temporal lobes regions of interest defined through the ASHS algorithm (Yushkevich et al., 2015), with theoretically driven cognitive assessment medial temporal lobes functions. The '4 mountains test' and the 'Memory entities' test will allow specific probing of hippocampal and rhinal cortices functions, respectively (Hartley et al., 2007; Besson et al., 2020).

25 patients with 'subjective cognitive decline-plus' (hereafter 'SCD', criteria of Jessen et al., 2014) and 25 patients with mild neurocognitive impairment due to Alzheimer's disease (hereafter 'MCI', criteria of Albert et al., 2011) matched for gender, socio-professional category and level of education. The 25 healthy volunteers required have already been included in a different study.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged between 50 and 80
  • native French speaking
  • right-handed
  • with a level of education equal to or higher than the Certificat d'Etudes Primaires (primary school leaving certificate)
  • free of any medical or psychiatric condition likely to interfere with cognition, other than a diagnosis of SCD / MCI
  • affiliated with a social security scheme
  • having received oral and written information abou the protocol and having signed a consent form to participate in this research
  • patients with 'subjective cognitive decline-plus' (hereafter 'SCD', criteria of Jessen et al., 2014) or patients with mild neurocognitive impairment due to Alzheimer's disease (hereafter 'MCI', criteria of Albert et al., 2011)

排除标准

  • contraindications to MRI : Abdominal circumference + upper limbs stuck to the body > 200 cm; Implantable pacemaker or defibrillator; Neurosurgical clips; Cochlear implants ; Neural or peripheral stimulator; Intra-orbital or encephalic metallic foreign bodies; Endoprostheses fitted less than 4 weeks ago and osteosynthesis devices fitted less than 6 weeks ago; Claustrophobia.
  • sensory deficit interfering with experimental tests
  • pregnant or breast-feeding women
  • adults under legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty
  • 7-items modified Hachinski ischemic score >2 (Hachinski et al., 2012)
  • Dementia (McKhann et al., 2011)

研究组 & 干预措施

SCD+

Experimental

Patients with subjective cognitive decline-plus due to Alzheimer's disease (or "DCS" in french)

干预措施: high-resolution diffusion MRI (Diagnostic Test)

MCI

Experimental

Patients with mild neurocognitive impairment due to Alzheimer's disease (or "TCL" in french)

干预措施: high-resolution diffusion MRI (Diagnostic Test)

结局指标

主要结局

Diffusion-MRI based parameters estimates of medial temporal lobe gray matter microstructure

时间窗: 2 hours and 30 minutes

Free-water and free-water corrected Fractional anisotropy are two parameters that can be estimated through Multi-Compartment Modelling of the diffusion MRI signal within medial temporal lobes gray matter. We will compute these parameters for the hippocampus and the surroundings rhinal cortices. These measures will be compared between patients and healthy controls.

次要结局

  • Relationships between medial temporal lobe gray matter microstructure and memory(2 hours and 30 minutes)
  • Diffusion-MRI based parameters estimates of medial temporal lobe gray matter microstructure(2 hours and 30 minutes)

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验